The NUB reimbursement pathway has been effective in bringing high-cost innovative medical technologies to the German market, but there are challenges. In MedTech Strategist, we assess the funding of medtech through NUBs and outlines the strengths and weaknesses of the NUB pathway.
CRA Insights: Blockchain & Crypto
Blockchain technologies are disrupting established industries as well as creating new ones. CRA’s experts bring the rigor of their expertise and credentials to...